Two audiences, one story, zero room for a loose claim.

Write the claim boundary before you write the pitch

The recurring failure in digital health communications is language that outruns the evidence — an efficacy verb where the data supports an association, or a clinical implication a product's intended use does not cover. We map every claim to its supporting evidence, write intended-use boundaries into the core messaging, and route it through your clinical, regulatory, and legal reviewers in week one, with named approvers and agreed turnaround windows.

• Claims matrix: assertion, supporting evidence, approved phrasing
• Intended-use boundaries stated in the core narrative
• Named clinical, regulatory, and legal approvers with turnaround windows
• No protected health information handled at any point

Four audiences, one approved core story

Clinicians want mechanism and evidence. Payers want cost and utilization. Employers want engagement. Patients want plain language and reassurance about their data. Investors want the market. Writing these separately produces contradictions that surface in press; we write one approved core narrative and derive each audience version from it, so the same facts hold everywhere.

Clinical credibility comes from named people

A chief medical officer or clinical advisory lead willing to publish and speak does more for healthtech credibility than a launch campaign. We build that visibility deliberately — trade bylines, clinical podcasts, health-industry panels, and commentary on the operational problems your product touches — while keeping every statement inside what your evidence supports.

Evidence moments are the news pipeline

Study results, pilot outcomes, health-system partnerships, and peer-reviewed publications are the announcements this sector rewards. We plan the year around the evidence calendar rather than the marketing calendar, so coverage arrives attached to something verifiable and reporters have a reason to write.